Aevum outperforms expectations from IOR merger
NSW based Aevum has informed the stock market that its operating cash flow for the year will be $3-$5 million higher than the $21.2 million it forecast when it announced its merger with the Victorian-based IOR group in January this year. Net profit...
NSW based Aevum has informed the stock market that its operating cash flow for the year will be $3-$5 million higher than the $21.2 million it forecast when it announced its merger with the Victorian-based IOR group in January this year. Net profit after tax is now predicted to be $14-16 million for this financial year from its 3,100 ILUs and 367 beds.
